Free Trial
NYSEAMERICAN:FOXO

FOXO Technologies Q3 2023 Earnings Report

FOXO Technologies logo
$0.47 +0.01 (+1.30%)
As of 12:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FOXO Technologies EPS Results

Actual EPS
-$7.50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

FOXO Technologies Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

FOXO Technologies Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
Friday, January 19, 2024
Conference Call Time
7:00AM ET

Upcoming Earnings

FOXO Technologies' Q2 2025 earnings is scheduled for Wednesday, June 4, 2025

Earnings Documents

FOXO Technologies Earnings Headlines

Trump’s Bitcoin Reserve is No Accident…
For the first time in history, we have a president who understands crypto's potential to bypass the banking system entirely. And Wall Street's biggest players know it. I've created a blueprint revealing how everyday investors can turn this historic shift into potentially life-changing wealth. Like the 75,000 new millionaires created in the last bull run— only this time with institutional backing.
FOXO Reaches Key Milestone, Shares Pop
See More FOXO Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like FOXO Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on FOXO Technologies and other key companies, straight to your email.

About FOXO Technologies

FOXO Technologies (NYSEAMERICAN:FOXO) engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.

View FOXO Technologies Profile

More Earnings Resources from MarketBeat